PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Apr-2021 Vālenz® Announces Acquisition of Kozani Health Businesswire
01-Apr-2021 OSE Immunotherapeutics Receives Authorization for Phase 1 Clinical Trial of its Multi-Target Multi-Variant COVID-19 Vaccine Businesswire
01-Apr-2021 Eurofins Scientific: Make-whole Redemption Notice to the Bondholders Businesswire
01-Apr-2021 New AGNES Vitals Connect Streamlines Vitals Capture and Documentation for Skilled Nursing Facilities Businesswire
01-Apr-2021 Carbon Health Appoints Jim Alling and Julie Smith to Board of Directors Businesswire
01-Apr-2021 Pharma Logistics Wins Department of Defense Contract to Provide Pharmaceutical Reverse Distribution Services Businesswire
01-Apr-2021 Takeda organise une téléconférence sur ses produits en développement de première phase Businesswire
01-Apr-2021 Takeda veranstaltet Telefonkonferenz zu Marktchancen der Welle-1-Pipeline Businesswire
01-Apr-2021 Takeda tiene un webcast riguardante il mercato per la sua pipeline Wave 1 Businesswire
01-Apr-2021 Takeda Organiza Chamada de Oportunidades de Mercado da Linha de Produtos Wave 1 Businesswire
01-Apr-2021 Takeda Hosts Wave 1 Pipeline Market Call Businesswire
01-Apr-2021 Amit Chadha Takes Charge as CEO & MD of L&T Technology Services Businesswire
01-Apr-2021 Valkyrie Group Places Big Bet With Hair Growth Pharmaceutical Firm Aneira Pharma, Inc. Newswire
01-Apr-2021 The Global Articulated Robots Market is Expected to Reach $33+ Billion by 2026 - ResearchAndMarkets.com Businesswire
01-Apr-2021 PharmaCyte Biotech Successfully Completes 1 Year Stability Study Businesswire
01-Apr-2021 AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration Businesswire
01-Apr-2021 Smiths Medical and Bainbridge Health Partner to Offer Webinar on Emerging Trends in Intravenous Medication Safety and Utilization Businesswire
01-Apr-2021 ANDEXANET ALFA (ONDEXXYA®) NICE FAD Media Statement Alexion Pharmaceuticals
01-Apr-2021 Surmodics Announces Successful First Patient Uses of Two Sublime™ Radial Access Platform Devices Businesswire
01-Apr-2021 CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million on a Pro Forma Basis in 2020 Businesswire